Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of GLA5PR GLARS-NF1 Tab. for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain of Mononeuropathy

Drugs mentioned

• GLA5PR GLARS-NF1 Tab.

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Pain of Mononeuropathy | Phase 3 | Status: COMPLETED